Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Debt / Equity

AMERICAN SHARED HOSPITAL SERVICES Debt/Equity Ratio

The debt/equity ratio shows how much a company has borrowed for every dollar its shareholders have put in. It is long-term debt, both the part due within a year and the rest, divided by shareholder equity, shown as a multiple with both amounts in the table. A higher ratio means the company relies more on borrowed money than on shareholder capital. Because equity shrinks through buybacks or losses, the ratio can rise even when debt is unchanged, and it has no meaning when equity is negative. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for the quarter ending 2026-06-30 was 1.26, a 25.15% increase year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for the quarter ending 2026-03-31 was 1.26, a 59.83% increase year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for the quarter ending 2025-12-31 was 1.25, a 61.78% increase year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for the quarter ending 2025-09-30 was 1.27, a 125.72% increase year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for fiscal 2025 was 1.25, a 61.78% increase from fiscal 2024.
  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for fiscal 2024 was 0.77, a 32.38% increase from fiscal 2023.
  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for fiscal 2023 was 0.58, a 0.42% increase from fiscal 2022.
  • AMERICAN SHARED HOSPITAL SERVICES debt/equity ratio for fiscal 2022 was 0.58, a 15.85% decline from fiscal 2021.
Available history
2011-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2026-06-301.26$32.43M$25.81M
2026-03-311.26$33.69M$26.71M
2025-12-311.25$34.69M$27.69M
2025-09-301.27$36.37M$28.6M
2025-06-301$28.97M$28.85M
2025-03-310.79$23.05M$29.21M
2024-12-310.77$23.25M$30.03M
2024-09-300.56$17.93M$31.83M
2024-06-300.56$18.12M$32.35M
2024-03-310.69$18.31M$26.39M
2023-12-310.58$15.37M$26.28M
2023-09-300.51$13.37M$26M
2023-06-300.53$13.61M$25.74M
2023-03-310.54$14.02M$25.82M
2022-12-310.58$14.93M$25.63M
2022-09-300.6$15.14M$25.43M
2022-06-300.66$16.79M$25.34M
2022-03-310.69$17.01M$24.72M
2021-12-310.69$16.78M$24.24M
2021-09-300.71$16.9M$23.95M
2021-06-300.71$16.93M$23.71M
2021-03-310.21$5.1M$23.84M
2020-12-310.24$5.78M$23.65M
2020-09-300.2$6.15M$30.71M
2020-06-300.21$6.54M$30.97M
2020-03-310.19$5.83M$31.47M
2019-12-310.16$5.01M$31.81M
2019-09-300.18$5.56M$31.42M
2019-06-300.2$6.46M$31.75M
2019-03-310.22$6.98M$31.48M
2018-12-310.24$7.57M$31.05M
2018-09-300.2$6.26M$31.02M
2018-06-300.22$6.96M$31.07M
2017-12-310.28$8.52M$29.89M
2016-12-310.35$9.52M$27.17M
2015-12-310.49$12.27M$25.18M
2014-12-310.49$12.73M$26.15M
2013-12-310.85$20.35M$24.06M
2012-12-310.87$21.7M$24.83M
2011-12-310.77$19.31M$25.17M

Annual Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2025-12-311.25$34.69M$27.69M
2024-12-310.77$23.25M$30.03M
2023-12-310.58$15.37M$26.28M
2022-12-310.58$14.93M$25.63M
2021-12-310.69$16.78M$24.24M
2020-12-310.24$5.78M$23.65M
2019-12-310.16$5.01M$31.81M
2018-12-310.24$7.57M$31.05M
2017-12-310.28$8.52M$29.89M
2016-12-310.35$9.52M$27.17M
2015-12-310.49$12.27M$25.18M
2014-12-310.49$12.73M$26.15M
2013-12-310.85$20.35M$24.06M
2012-12-310.87$21.7M$24.83M
2011-12-310.77$19.31M$25.17M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45